Stockscreener 앱 받기
16.61
8.61%
1.28
전일 마감가:
$15.33
열려 있는:
$15.34
하루 거래량:
862.31K
Relative Volume:
0.64
시가총액:
$1.28B
수익:
$54.55M
순이익/손실:
$-193.57M
주가수익비율:
-5.7474
EPS:
-2.89
순현금흐름:
$-181.86M
1주 성능:
+30.08%
1개월 성능:
+59.79%
6개월 성능:
+70.25%
1년 성능:
-25.57%
1일 변동 폭
$15.25
$16.74
1주일 범위
$12.43
$16.74
52주 변동 폭
$8.18
$23.00
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
16.65 | 1.55B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.25 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.72 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.20 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.42 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.38 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
First Week of July 2026 Options Trading For Nurix Therapeutics (NRIX) - Nasdaq
How analysts rate Nurix Therapeutics Inc. stock todayQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 10.4%Should You Buy? - MarketBeat
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 Volume & Community Consensus Picks - newser.com
Patient Square Capital LP Has $4.70 Million Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Key metrics from Nurix Therapeutics Inc.’s quarterly dataWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Will Nurix Therapeutics Inc. stock outperform Nasdaq indexTake Profit & Verified Momentum Watchlists - newser.com
How moving averages guide Nurix Therapeutics Inc. tradingTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Why Nurix Therapeutics Inc. stock is a must watch in 20252025 Market Overview & Daily Price Action Insights - newser.com
Can Nurix Therapeutics Inc. recover in the next quarter2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
What to expect from Nurix Therapeutics Inc. in the next 30 daysBull Run & Fast Momentum Entry Tips - newser.com
Candriam S.C.A. Sells 326,547 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Inc. stock daily chart insights2025 Institutional Moves & Fast Exit and Entry Trade Guides - newser.com
Signal strength of Nurix Therapeutics Inc. stock in tech scannersMarket Activity Summary & Safe Entry Point Alerts - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.Quarterly Trade Review & Reliable Breakout Forecasts - newser.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Visual trend scoring systems applied to Nurix Therapeutics Inc.2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Nurix Therapeutics Inc. stock sustain high P E ratiosWeekly Investment Report & Fast Moving Trade Plans - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBond Market & Capital Protection Trading Alerts - newser.com
Is Nurix Therapeutics Inc. stock ready for breakoutEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Analyzing Nurix Therapeutics Inc. with risk reward ratio chartsJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of Nurix Therapeutics Inc. stockQuarterly Portfolio Report & Smart Swing Trading Techniques - newser.com
What analysts say about Nurix Therapeutics Inc stockAnalyst Downgrades & Small Budget Capital Gain - earlytimes.in
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
0.74%
자본화:
|
볼륨(24시간):